Task: Answer the multiple choice question.
Question: Which compound exhibits a -12.080% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
(a) CCCCn1c(SCC(=O)c2ccc(O)cc2O)nc2cc(S(N)(=O)=O)ccc21
(b) Cc1cc(C)cc(NC(=O)C2CCCN2/C=C/C(=O)C(F)(F)F)c1
Answer: b. Cc1cc(C)cc(NC(=O)C2CCCN2/C=C/C(=O)C(F)(F)F)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc(C)cc(NC(=O)C2CCCN2/C=C/C(=O)C(F)(F)F)c1
Cc1cc(C)cc(NC(=O)C2CCCN2/C=C/C(=O)C(F)(F)F)c1
N-(3,5-dimethylphenyl)-1-[(E)-4,4,4-trifluoro-3-oxobut-1-enyl]pyrrolidine-2-carboxamide